Fertility and Sterility
Volume 93, Issue 1 , Pages 184-191, 1 January 2010

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy

Presented at the Endocrine Society of Australia National Meeting, Christchurch, New Zealand, September 2–5, 2007, and the American Endocrine Society Annual Meeting, San Francisco, California, June 15–18, 2008.

  • Helena J. Teede, Ph.D.

      Affiliations

    • The Jean Hailes Foundation for Women's Health, Monash Institute of Health Services Research, Monash University, Melbourne, Victoria, Australia
    • Diabetes Unit, Southern Health, Melbourne, Victoria, Australia
    • ,
  • Caroline Meyer, Ph.D.

      Affiliations

    • Diabetes Unit, Southern Health, Melbourne, Victoria, Australia
    • ,
  • Samantha K. Hutchison, M.B., B.S.

      Affiliations

    • The Jean Hailes Foundation for Women's Health, Monash Institute of Health Services Research, Monash University, Melbourne, Victoria, Australia
    • ,
  • Sophia Zoungas, Ph.D.

      Affiliations

    • The Jean Hailes Foundation for Women's Health, Monash Institute of Health Services Research, Monash University, Melbourne, Victoria, Australia
    • Diabetes Unit, Southern Health, Melbourne, Victoria, Australia
    • ,
  • Barry P. McGrath, M.D.

      Affiliations

    • Department of Vascular Sciences and Medicine, Centre for Vascular Health, Monash University, Clayton, Victoria, Australia
    • ,
  • Lisa J. Moran, Ph.D.

      Affiliations

    • The Jean Hailes Foundation for Women's Health, Monash Institute of Health Services Research, Monash University, Melbourne, Victoria, Australia
    • Corresponding Author InformationReprint requests: Lisa J. Moran, Ph.D., The Jean Hailes Foundation for Women's Health, Monash Institute of Health Services Research, Locked bag 29, Monash Medical Centre, 246 Clayton Rd., Clayton, Victoria 3168, Australia (FAX: 61-03-9594-7554).

Received 3 April 2008; received in revised form 5 September 2008; accepted 6 September 2008. published online 18 November 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 H.J.T. has nothing to disclose. C.M. has nothing to disclose. S.K.H. has nothing to disclose. S.Z. has nothing to disclose. B.P.M. has served on the Cardiovascular Advisory Boards of Boehringer Ingelheim and Solvay Pharmaceuticals. L.J.M. has nothing to disclose.

 This work was an investigator-initiated trial supported by a competitive Cardiovascular Lipid (CVL) Research Grant sponsored by Pfizer Australia and through internal department funds. H.J.T. received a National Health and Medical Research Council Career Development Award. L.J.M. received the Jean Hailes Fellowship.

PII: S0015-0282(08)03932-0

doi:10.1016/j.fertnstert.2008.09.034

Fertility and Sterility
Volume 93, Issue 1 , Pages 184-191, 1 January 2010

Article Tools

* Image Usage & Resolution